Natural history of Barth syndrome: a national cohort study of 22 patients-Reference-Cited by-同舟云学术

Natural history of Barth syndrome: a national cohort study of 22 patients

Published:2013 Issue:1 Volume:8 Page:70
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet Journal of Rare Diseases

Author:

Rigaud Charlotte,Lebre Anne-Sophie,Touraine Renaud,Beaupain Blandine,Ottolenghi Chris,Chabli Allel,Ansquer Helene,Ozsahin Hulya,Di Filippo Sylvie,De Lonlay Pascale,Borm Betina,Rivier Francois,Vaillant Marie-Catherine,Mathieu-Dramard Michèle,Goldenberg Alice,Viot Géraldine,Charron Philippe,Rio Marlene,Bonnet Damien,Donadieu Jean

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics(clinical),General Medicine

Reference38 articles.

1. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes

2. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria

3. Eponym

4. A novel X-linked gene, G4.5. is responsible for Barth syndrome

5. Cardiolipin metabolism and Barth Syndrome

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barth syndrome in an adult patient: an overview of the problem and case report. A review;Terapevticheskii arkhiv;2024-09-14

2. Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER;Genetics in Medicine;2024-07

3. Hematologic Manifestations in Primary Mitochondrial Diseases;Journal of Pediatric Hematology/Oncology;2024-06-10

4. Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy;Frontiers in Molecular Medicine;2024-04-29

5. Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth Syndrome;2024-04-29